India to Netherlands: Imatinib Export Trade Route

The India to Netherlands Imatinib corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $504.7K USD. The route is dominated by HETERO LABS LIMITED, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's imatinib manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $56.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with imatinib's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 33.7%, placing it at rank #18 among India's top imatinib export destinations globally.

On the import side, key buyers of Indian imatinib in Netherlands include ACCORD HEALTHCARE B V, XXAROXXPHAXXA BXX, XXAROXXPHAXXA GXXH and 1 others. ACCORD HEALTHCARE B V is the single largest importer with 4 shipments valued at $179.2K USD.

India's imatinib exports to Netherlands are driven primarily by a handful of large-scale manufacturers. HETERO LABS LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — HETERO LABS LIMITED, INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $56.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as imatinib400mg 3x10t alu accord-pp-de and imatinib 400mg (9x10's), suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD HEALTHCARE B V is the largest importer with 4 shipments worth $179.2K USD — representing 35% of all imatinib imports from India on this route.